“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to discuss the necessity and viability of orphan and rare disease research - for both patients and VC investors alike.
What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host...
"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....
The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...